Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immuncell-LC plus Nexavar in Advanced Hepatocellular Carcinoma
NCT01897610Phase 2Completed
- Sponsor
- GC Cell
- Start
- Dec 2013
- Primary completion
- Jul 2017
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of immuncell-lc in hepatocellular carcinoma (HCC), sponsored by GC Cell. Started Dec 2013; status: completed.
02
Drugs
immuncell-lc
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01897610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01897610.